These exosomes were enriched in wtEGFR protein and could be delivered to mutEGFR NSCLC cells, resulting in activation of PI3K/AKT and MAPK pathways under the stress of osimertinib. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.